In a report released today, Iain Simpson from Barclays maintained a Buy rating on Haleon PLC (HLN – Research Report), with a price target ...

In a report released today, Guillaume Delmas from UBS maintained a Buy rating on Haleon PLC (HLN – Research Report), with a price target ...

Starboard has a roughly $1 billion stake in the drugmaker and approached former Pfizer CEO Ian Read and ex-CFO Frank D'Amelio, both of whom expressed interest in supporting the activist investor's ...

The drugmaker has cut costs already and has no coming product approvals or research that could offer a quick lift.

Goldman Sachs raises AstraZeneca price target to 16,046 (15,914) pence - 'buy' Barclays raises Standard Chartered price target to 890 (850) pence - 'equal weight' Barclays raises Harbour Energy price ...

Pfizer is in value territory, trading at just 10.74X forward earnings with a 5.88% annual dividend yield and over $10 billion in cash after selling $2.4 billion of its HLN position.

Fair trade regulator CCI on Tuesday cleared JM Financial's proposed acquisition of a 43 per cent stake in JM Financial Credit ...

The Strategy underperformed its benchmark during a volatile quarter, as detractors in the financials and industrials sectors ...

London markets ended Tuesday on a weaker note, weighed down by investor disappointment over the absence of new stimulus ...

Michael Byrne, CEO of WLR, said the radio station is delighted to be involved to both champion and promote the Waterford ...

India Nutritional Supplements Market was valued at U$ 11.85 billion in 2023 and is projected to hit the market valuation of US$ 28.70 billion by 2032 at a CAGR of 10.7% during the forecast period 2024 ...

Democratic Vice President Kamala Harris led Republican Donald Trump by a marginal three percentage points - 46% to 43% - as the two remain locked in a close race to win the Nov. 5 U.S ...